ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011

Prostatic Cancer Workshop Reports On Etiology, Diagnosis, Treatment

September 10, 1976

ACS Presents Awards To Anti-Tobacco Activists.

July 21, 2006

John Niederhuber Named Acting NCI Director.

June 2, 2006

Minimally Invasive Surgery Results In Lower Mortality Rate For Esophageal Removal

April 25, 2003